Literature DB >> 14824399

Pathogenesis of coxsackie virus infection; multiplication of virus and evolution of the muscle lesion in mice.

J L MELNICK, G C GODMAN.   

Abstract

The quantitative distribution of the Conn.-5 strain of Coxsackie virus in different tissues was determined by serial titration at intervals after inoculation of 4 to 5 day old mice. High titers were reached by the 2nd day in blood, heart, liver, muscle, intestine, and its contents, and these were maintained through the 8th day, except for the blood, in which the virus level fell earlier. In paralyzed mice, muscle and brain attained the highest titers and it was in these tissues alone that virus persisted through the 9th day of illness. The pathology of the infection has been briefly described. In particular, the evolution of morbid changes in striated muscle was correlated with the concentrations of virus in muscle. Acute muscle necrosis first occurred when there was a peak viral concentration (4th day), and reached maximal intensity on the 8th day. Scattered acute lesions continued to appear while the virus titer remained above 10(-4), from the 9th to 12th day. With the decrease in the myositis, there was a concomitant decrease in the incidence of perceptible disease. Inflammation was found to follow upon the development of necrosis, and subsided slowly. Regeneration began very early, became exuberant, and led finally to restitution of the muscle.

Entities:  

Keywords:  COXSACKIE VIRUSES

Mesh:

Year:  1951        PMID: 14824399      PMCID: PMC2136090          DOI: 10.1084/jem.93.3.247

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  11 in total

1.  The efficiency of intramuscular anastomoses, with observations on the regeneration of devascularized muscle.

Authors:  W E Clark; L B Blomfield
Journal:  J Anat       Date:  1945-01       Impact factor: 2.610

2.  A virus isolated from patients diagnosed as non-paralytic poliomyelitis or aseptic meningitis.

Authors:  J L MELNICK; E W SHAW; E C CURNEN
Journal:  Proc Soc Exp Biol Med       Date:  1949-07

3.  Spontaneous cardiac lesions in mice; their bearing on attempts to produce experimental carditis.

Authors:  F G GRAY
Journal:  Am J Pathol       Date:  1949-11       Impact factor: 4.307

4.  The Coxsackie viruses.

Authors:  G DALLDORF
Journal:  Bull N Y Acad Med       Date:  1950-05

5.  Studies on the Coxsackie viruses; properties, immunological aspects and distribution in nature.

Authors:  J L MELNICK
Journal:  Bull N Y Acad Med       Date:  1950-05

6.  A virus recovered from the feces of poliomyelitis patients pathogenic for suckling mice.

Authors:  G DALLDORF; G M SICKLES
Journal:  J Exp Med       Date:  1949-06-01       Impact factor: 14.307

7.  Myositis in mice following intramuscular injection of viruses of the mouse encephalomyelitis group and of certain other neurotropic viruses.

Authors:  R RUSTIGIAN; A M PAPPENHEIMER
Journal:  J Exp Med       Date:  1949-01       Impact factor: 14.307

8.  A viral agent isolated from a case of "non-paralytic poliomyelitis" and pathogenic for suckling mice: its possible relation to the coxsackie group of viruses.

Authors:  F S CHEEVER; J B DANIELS; E F HERSEY
Journal:  J Exp Med       Date:  1950-08       Impact factor: 14.307

9.  THE LIMITED NEUROTROPIC CHARACTER OF THE ENCEPHALITIS VIRUS (ST. LOUIS TYPE) IN SUSCEPTIBLE MICE.

Authors:  L T Webster; A D Clow
Journal:  J Exp Med       Date:  1936-02-29       Impact factor: 14.307

10.  Lesions caused in suckling mice by certain viruses isolated from cases of so called non-paralytic poliomyelitis and of pleurodynia.

Authors:  A M PAPPENHEIMER; J B DANIELS; F S CHEEVER; T H WELLER
Journal:  J Exp Med       Date:  1950-08       Impact factor: 14.307

View more
  19 in total

1.  COXSACKIE VIRUS B3 MYOCARDITIS IN MICE. AN ELECTRON MICROSCOPIC, IMMUNOFLUORESCENT AND VIRUS-ASSAY STUDY.

Authors:  E R RABIN; S A HASSAN; A B JENSON; J L MELNICK
Journal:  Am J Pathol       Date:  1964-05       Impact factor: 4.307

2.  Factors influencing host-virus interactions. I. A comparison of viral multiplication and histopathology in infant, adult, and cortisone-treated adult mice infected with the Conn. -5 strain of Coxsackie virus.

Authors:  W D BORING; D M ANGEVINE; D L WALKER
Journal:  J Exp Med       Date:  1955-12-01       Impact factor: 14.307

3.  Studies on poliomyelitis in Ontario. VI. Additional laboratory studies on cases of clinical poliomyelitis excreting Coxsackie virus.

Authors:  A J RHODES; E M CLARK; W WOOD; F T SHIMADA; N SILVERTHORNE; J B J MCKENDRY; D DUNCAN; C S ANGLIN
Journal:  Can Med Assoc J       Date:  1953-05       Impact factor: 8.262

4.  [Morphological principles for new opinions on the pathological picture of poliomyelitis].

Authors:  R GADEKE
Journal:  Virchows Arch Pathol Anat Physiol Klin Med       Date:  1952

Review 5.  Coxsackievirus infection as a trigger of cardiac autoimmunity.

Authors:  L J Wolfgram; N R Rose
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

6.  The histopathology of Coxsackie virus infection in mice. I. Morphologic observations with four different viral types.

Authors:  G C GODMAN; H BUNTING; J L MELNICK
Journal:  Am J Pathol       Date:  1952 Mar-Apr       Impact factor: 4.307

7.  An outbreak of epidemic pleurodynia, with special reference to the laboratory diagnosis of Coxsackie virus infections.

Authors:  A S LAZARUS; E A JOHNSTON; J E GALBRAITH
Journal:  Am J Public Health Nations Health       Date:  1952-01

8.  The histopathology of Coxsackie virus infection in mice. II. Histochemical observations on the lesions in muscle and fat.

Authors:  G C GODMAN; H BUNTING; J L MELNICK
Journal:  Am J Pathol       Date:  1952 Jul-Aug       Impact factor: 4.307

9.  Initiation and spreading of coxsackievirus A 1 infection in muscles of newborn mice.

Authors:  K Bienz; D Egger; H Loeffler
Journal:  Experientia       Date:  1972-06-15

10.  In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug.

Authors:  M G Woods; G D Diana; M C Rogge; M J Otto; F J Dutko; M A McKinlay
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.